ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2431

Are Occupational Therapy Interventions Included in the Most Commonly Used European Clinical-Practice Guidelines for the Management of Osteoarthritis?

Michaela Stoffer1, Doris Taurok2, Birgit Prodinger3, Josef S. Smolen4, Anthony D. Woolf5 and Tanja A. Stamm6, 1Internal Medicine III, division of rheumatology, Medical University of Vienna, Vienna, Austria, 2Orthopaedic Hospital Vienna Speising, 1130 Wien, Austria, 3Graduate Program in Health and Rehab Sciences, University of Western Ontario, London, ON, Canada, 4Division of Rheumatology, Department of Internal Medicine III,, Medical University of Vienna and Hietzing Hospital, Vienna, Austria, 5Rheumatology Dept, Royal Cornwall Hospital, Truro Cornwall, United Kingdom, 6Rheumatology, Medical University of Vienna, Vienna, Austria

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Occupational therapy and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Physical/Occupational Therapy and Exercise in Patients with Rhematologic Disease

Session Type: Abstract Submissions (ARHP)

Background/Purpose : The EUMUSC.net project facilitates cooperation between EU Member States and promotes a comprehensive European strategy to optimise musculoskeletal health.

Part of the EUMUSC.net project was devoted to retrieving clinical practice guidelines (CPG) for Osteoarthritis (OA) and to appraise them critically. The purpose of this study was to identify the relevance given to occupational therapy interventions.

Methods: National rheumatological scientific societies, social leagues and health professional associations were contacted and asked to provide relevant documents. Furthermore, a systematic review of the respective literature was conducted in Medline, CINAHL and the Internet. Documents fulfilling pre-defined inclusion and exclusion criteria have been critically appraised by two independent assessors using the AGREE II Instrument. The appraised documents were examined for occupational therapy interventions/occupational therapy (OT).

Results: Six guidelines/recommendations have been included into this study and appraised using the AGREE II Instrument. All six CPGs obtained the highest scores in the domain “Scope and Purpose” followed by remarkably high scores in the domain “Rigor of Development”.

Four CPGs had low scores in the domain “Stakeholder Involvement” and five in the domain “Applicability”. We identified ten interventions relevant to occupational therapy: adapting the environment, assistive devices for activities of daily living, hand exercise, joint protection, comprehensive occupational therapy, patient education, self management, splinting/orthoses, thermotherapy and walking assistive devices. Only “patient education” was recommended in all CPGs. “Adapting the environment” in one.

Conclusion: All six guidelines/recommendations addressed occupational therapy interventions. Two CPGs were referring to the term occupational therapy while the others did not. In all appraised documents no occupational therapist could be identified to be a member of an OA Guideline development group.


Disclosure:

M. Stoffer,
None;

D. Taurok,
None;

B. Prodinger,
None;

J. S. Smolen,

Abbott Immunology Pharmaceuticals, Roche, MSD, Pfizer, UCB, BMS,

2,

Abbott Immunology Pharmaceuticals, Roche, MSD, Pfizer, UCB, BMS, Novo-Nordisk, Lilly, Atsra-Zeneca, Glaxo, Dandoz, Sanofi, Medimmune,

5,

Abbott Immunology Pharmaceuticals, Roche, MSD, Pfizer, UCB, BMS,

,

Rheumatology 5E,

;

A. D. Woolf,
None;

T. A. Stamm,

Abbott Immunology Pharmaceuticals,

5.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/are-occupational-therapy-interventions-included-in-the-most-commonly-used-european-clinical-practice-guidelines-for-the-management-of-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology